Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 3012345...102030...Last »

Obamacare Patients Use More Birth Control, But Fewer Prescriptions In Year Two

In what may slow the growth of premiums for Americans purchasing coverage on public exchanges under the Affordable Care Act, a new report shows 2015 enrollees using fewer prescriptions than those who signed up for coverage in 2014. Express Scripts (ESRX), one of the nation’s largest managers of prescription drugs, said the number of new […]

Read More »

Health Firms Paid $6.49 Billion to Doctors, Hospitals in 2014

Drug and medical-device makers paid $6.49 billion to U.S. doctors and teaching hospitals during 2014, according to the federal government’s first full-year accounting of the breadth of industry financial ties with medical providers. The tally comprises company payments to more than 600,000 doctors and 1,100 hospitals for services such as consulting, research and promotional speeches […]

Read More »

Biogen’s $1.06 Billion Plant in the Greater Zurich Area Will Create 400 New Jobs

Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn Planned ZURICH, July 1, 2015 /CNW/ – Biogen Inc. (NASDAQ: BIIB), one of the world’s leading biotechnology companies, is investing one billion Swiss francs in Luterbach in the canton of Solothurn in a new production plant. Up to 400 new jobs […]

Read More »

GlaxoSmithKline Discloses $175K Paid to Hundreds of North Carolina Doctors

Last year, 244 doctors in Raleigh, Durham and Chapel Hill received a combined $175,797 from drug maker GlaxoSmithKline (NYSE: GSK). Of that, one physician, Dr. Edward Nolan Pattishall, received $59,000 and another, Dr. Roger S. Rittmaster, received $37,400. No other physician received more than $8,300 and only 20 physicians received more than $1,000. The majority […]

Read More »

London Mayor Suggests $15 Billion Megafund To Boost Biotech

Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) “megafund” to help biotech firms in London and across Britain compete with U.S. rivals, London mayor Boris Johnson said on Thursday. Britain is a leader in academic scientific work and also home to two of the world’s top drugmakers – GlaxoSmithKline and […]

Read More »

Baxter International Spinout Finally Has Long Awaited Launch

Baxalta Incorporated, a pharmaceutical spinout of Illinois-based Baxter International (BAX), finally launched with hopes of fielding 20 new products by 2020, the company announced this morning.   The new company, which trades under the BXLT ticker symbol, will focus on developing products for the hematology, oncology and immunology markets. The launch of Baxalta has been […]

Read More »

U.S. doctors, hospitals reap $6.5 billion from drug and device makers: report

U.S. doctors and research hospitals collected nearly $6.5 billion in payments for services rendered to pharmaceutical and medical device companies in 2014, according to the Centers for Medicare & Medicaid Services (CMS) Open Payments report released on Tuesday. The report, in its second year, lists 11.4 million payments to 607,000 physicians and more than 1,100 […]

Read More »

New App Could Save Lives Through Early Pneumonia Detection

A team from Uganda’s Makerere University is the only African winner in the 2014-2015 Big Ideas Contest for its app that could aid in early detection of pneumonia. The app, which won Makerere a tie for second place in the global health category of the contest, combines a cell phone prototype with specially developed cell […]

Read More »

Health Insurance Premiums Are Rising Faster Than Income

In every budget, we can control what we pay for some items while others are out of our control. Health insurance premiums are one of those items over which the consumer has little or no control (outside of raising the deductible or changing to an inferior plan). In this article, we’ll look at the rise […]

Read More »

Half of heart disease deaths due to preventable factors

In the U.S., preventable risk factors still account for 50 percent of deaths from cardiovascular disease among adults age 45 to 79, according to a new analysis. But even if every state brought levels of those risk factors – such as obesity and smoking – down to the best level any state has so far […]

Read More »

Genentech’s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market

South San Francisco, Calif.-based Genentech (RHHBY) announced today that its clinical studies of ocrelizumab compared to interferon beta-1a (Rebif) in relapsing multiple sclerosis (MS) met their primary and major secondary endpoints.   Two Phase III studies are being conducted, OPERA I and OPERA II. The primary endpoint of both studies was annualized protocol-defined relapse rate […]

Read More »

California governor signs bill limiting school vaccine exemptions

California Governor Jerry Brown on Tuesday signed a bill eliminating the state’s personal beliefs exemption for school vaccine requirements – legislation that was prompted by a measles outbreak at Disneyland linked to low vaccination rates. The new law, which makes California only the third state to eliminate religious and other personal vaccine exemptions, generated vociferous […]

Read More »

Cuba named first country to end mother-to-child HIV transmission

The World Health Organization on Tuesday declared Cuba the first country in the world to eliminate the transmission of HIV and syphilis from mother to child. The WHO said in a statement that an international delegation that it and the Pan American Health Organization sent to Cuba in March determined the country met the criteria […]

Read More »

Beware of animal diseases as biological weapons, health experts say

The World Health Organization, animal health and national defense officers called on Tuesday for wider international cooperation to avoid the spread of animal diseases that could be used as biological weapons. Sixty percent of human diseases come from animal agents and 80 percent of the agents that could be used for bio terrorism are of […]

Read More »

Sugary Drinks Linked To Many Thousands Of Deaths Globally

More morbid news for sugar: Researchers calculate that sugary drinks alone are responsible for many thousands of deaths per year. And this adds to an increasing shift in the nutritional tide. Dietary fat – which was once the biggest culprit – is now getting a reprieve, as the upper limit on fat intake has just been scrapped in […]

Read More »

New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State

SACRAMENTO, Calif., June 30, 2015 /PRNewswire/ — A new analysis and infographic released today estimate California’s exposure to high-priced Hepatitis C medications could range from hundreds of millions of dollars, even if only 5 percent of Californians infected with Hepatitis C receive treatment through state programs. The analysis, which looks at the costly impact of […]

Read More »

Eolas Therapeutics and AstraZeneca Partner to Develop Orexin-1 Receptor Antagonist for Multiple Indications

CARLSBAD, Calif., June 30, 2015 /PRNewswire/ — Eolas Therapeutics, Inc. announced today that is has entered into a worldwide license and partnership agreement with AstraZeneca on the Eolas Orexin-1 Receptor Antagonist (EORA) program for smoking cessation and other indications. The EORA program was awarded a Blueprint Neurotherapeutics (BPN) grant from the National Institutes of Health (NIH) […]

Read More »

Novartis to test new pricing model with heart failure drug

Novartis plans to test a novel pricing model with some customers when it launches its keenly awaited new heart failure drug Entresto, the Swiss company’s head of pharmaceuticals said on Tuesday. Entresto, also known as LCZ696, is the first new drug in decades for helping patients whose lives are in danger because their hearts cannot […]

Read More »

Did Celgene’s Billion Dollar Deal With Juno Just Save The Biotech Bull Market?

Just when you think a biotech bear market is about to descend, the bulls come rushing in. News of a Greek default depressed markets yesterday and was only compounded by fears of a potential default by Puerto Rico.  Many of the large fund systems that are invested in too-good-to-be-true Puerto Rican bonds are also invested in […]

Read More »

Korean Healthtech Startup Closing In On Cure For Alzheimer’s

Korea’s startup landscape remains partial to gaming. Demand has been growing at such a staggering clip that the industry now accounts for 90% of the country’s mobile app revenues. The government is also providing financial assistance — to the tune of $90 million — to help shoulder rising demand. But though many welcome such incentives, the figures […]

Read More »

Page 1 of 3012345...102030...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation